Major depression diagnoses among patients with systemic sclerosis: Baseline and one-month followup

Arthritis Care and Research

Volumn 67, Issue 3, 2015, Pages 411-416

  Thombs, Brett D ^a   Jewett, Lisa R ^a   Kwakkenbos, Linda ^a   Hudson, Marie ^a   Baron, Murray ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; COMPOSITE INTERNATIONAL DIAGNOSTIC INTERVIEW; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; PATIENT MONITORING; PRACTICE GUIDELINE; PREVALENCE; PSYCHIATRIC DIAGNOSIS; REGISTER; SCLERODERMA; SYSTEMIC SCLEROSIS; WATCHFUL WAITING; AFFECT; AGED; CANADA; CLINICAL TRIAL; DEPRESSIVE DISORDER, MAJOR; MULTICENTER STUDY; PROGNOSIS; PSYCHOLOGY; REMISSION; RISK FACTOR; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; TIME; UNNECESSARY PROCEDURE;

AFFECT; AGED; ANTIDEPRESSIVE AGENTS; CANADA; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; REGISTRIES; REMISSION, SPONTANEOUS; RISK FACTORS; SCLERODERMA, SYSTEMIC; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; UNNECESSARY PROCEDURES; WATCHFUL WAITING;

EID: 84923282011     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22447     Document Type: Article

References (25)

1. Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 2013;52:2136-48.
2. Sheehy C, Murphy E, Barry M. Depression in rheumatoid arthritis: underscoring the problem. Rheumatology (Oxford) 2006;45:1325-7.
3. Jewett LR, Razykov I, Hudson M, Baron M, Thombs BD, and the Canadian Scleroderma Research Group. Prevalence of current, 12-month and lifetime major depressive disorder among patients with systemic sclerosis. Rheumatology (Oxford) 2013;52:669-75.
4. Mitchell AJ, Vaze A, Rao S. Clinical diagnosis of depression in primary care: a meta-analysis. Lancet 2009;374:609-19.
5. Mojtabai R, Olfson M. Proportion of antidepressants prescribed without a psychiatric diagnosis is growing. Health Aff (Millwood) 2011;30:1434-42.
6. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLOS Med 2008;5:e45.
7. Wakefield JC, Schmitz MF. Predictive validation of single-episode uncomplicated depression as a benign subtype of unipolar major depression. Acta Psychiatr Scand 2014;129:445-57.
8. Dowrick C, Frances A. Medicalising unhappiness: new classification of depression risks more patients being put on drug treatment from which they will not benefit. BMJ 2013;347:f7140.
9. Patten SB, Bilsker D, Goldner E. The evolving understanding of major depression epidemiology: implications for practice and policy. Can J Psychiatry 2008;53:689-95.
10. Davidson JR. Major depressive disorder treatment guidelines in America and Europe. J Clin Psychiatry 2010;71 Suppl E1:e04.
11. National Collaborating Centre for Mental Health. The NICE guideline on the management and treatment of depression in adults (updated edition). London: Royal College of Psychiatrists; 2010.
12. Alhajeri H, Hudson M, Fritzler MJ, Pope JE, Baron M, and the Canadian Scleroderma Research Group. Evaluation of the new American College of Rheumatology/European League Against Rheumatism criteria for the classification of systemic sclerosis in the Canadian Scleroderma Research Group cohort [abstract]. Arthritis Rheum 2013;65:S772.
13. Wittchen HU. Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 1994;28:57-84.
14. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
15. Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281-5.
16. Medsger TA Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999;26:2159-67.
17. He Y, Zhang M, Lin EH, Bruffaerts R, Posada-Villa J, Angermeyer MC, et al. Mental disorders among persons with arthritis: results from the World Mental Health Surveys. Psychol Med 2008;38:1639-50.
18. Patten SB. A major depression prognosis calculator based on episode duration. Clin Pract Epidemiol Ment Health 2006;2:13.
19. Patten SB. Accumulation of major depressive episodes over time in a prospective study indicates that retrospective prevalence estimates are too low. BMC Psychiatry 2009;9:19.
20. Moffitt TE, Caspi A, Taylor A, Kokaua J, Milne BJ, Polanczyk G, et al. How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychol Med 2010:40;899-909.
21. Patten SV, Williams JV, Lavorato DH, Bulloch AG, D'Arcy C, Streiner DL. Recall of recent and more remote depressive episodes in a prospective cohort study. Soc Psychiatry Psychiatr Epidemiol 2012;47:691-6.
22. Takayanagi Y, Spira AP, Roth KB, Gallo JJ, Eaton WW, Mojtabai R. Accuracy of reports of lifetime mental and physical disorders: results from the Baltimore Epidemiological Catchment Area Study. JAMA Psychiatry 2014;71:273-80.
23. Lockhart P, Guthrie B. Trends in primary care antidepressant prescribing 1995-2007: a longitudinal population database analysis. Br J Gen Pract 2011;61:e565-72.
24. Leavens A, Patten SB, Hudson M, Baron M, Thombs BD, for the Canadian Scleroderma Research Group. Influence of somatic symptoms on Patient Health Questionnaire-9 depression scores among patients with systemic sclerosis compared to a healthy general population sample. Arthritis Care Res (Hoboken) 2012;64:1195-1201.
25. Thombs BD, Fuss S, Hudson M, Schieir O, Taillefer SS, Fogel J, et al. High rates of depressive symptoms among patients with systemic sclerosis are not explained by differential reporting of somatic symptoms. Arthritis Rheum 2008;59:431-7.